Access to the PDF text

Free Article !

Archives of cardiovascular diseases
Volume 106, n° 4
page 259 (avril 2013)
Doi : 10.1016/j.acvd.2013.03.038

Prognostic signification of left atrial spontaneous contrast in patients with non valvular atrial fibrillation and a CHADS2 score=0

S. Lang, S. Ederhy, N. Haddour, L. Boyer Chatenet, C. Meuleman, G. Fleury, S. Adavane, E. Di Angelantonio
 Hôpital Saint-Antoine, Paris, France 

Background .– Transesophageal echocardiography (TEE) can detect left atrial (LA) thrombus and LA spontaneous echocardiographic contrast (SEC), which have been associated with a higher risk of thromboembolism in patients with atrial fibrillation (AF). We hypothesized that TEE-detected LASEC could predict cardiovascular events in AF in addition to clinical risk stratification in CHADS2 score=0 patients.

Methods .– Among 763 consecutive patients hospitalized for non valvular AF (NVAF), prior to cardioversion, TEE was systematically performed within 24h after admission; 205 patients had a CHADS2 score=0. All patients were followed-up (mean 6.3±4.3years) and cardiovascular (CV) events (stroke, death, or heart failure) defining a composite endpoint were recorded.

Results .– Mean age was 54.5±13.5years. NVAF was paroxysmal in 101patients (49.3%), persistent in 82 (40.0%) and permanent in 22 (10.7%). LA thrombus was found in one patient (0.5%), LASEC in 60 (29.3%), classified as mild in 43 (21.0%), moderate in 14 (6.8%) and severe in three (1.5%). One hundred seventy six (87.1%) were prescribed warfarin and 25 (12.4%) aspirin at hospital discharge. At follow-up, death occurred in 27 patients (13.2%), stroke in five (2.4%), heart failure in four (2.0%). AF recurrence was observed in 60 patients (29.3%) and haemorrhage requiring hospitalization in five (2.4%). The Kaplan-Meier (figure) curves showed that the presence of LASEC (Yes/No) was associated with a higher risk of CV events.

Conclusions .– TEE-detected LASEC is associated with a higher risk of CV events (stroke, death, or heart failure) at long-term follow-up in NVAF at very low risk of thromboembolism.

Top of the page

© 2013  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline